{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:04:40Z","timestamp":1790373880765,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cellsig.2024.111439","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:32:17Z","timestamp":1727458337000},"page":"111439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Bmal1 upregulates ATG5 expression to promote autophagy in skin cutaneous melanoma"],"prefix":"10.1016","volume":"124","author":[{"given":"Tao","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2024.111439_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2024.111439_bb0010","first-page":"221","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.cellsig.2024.111439_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11427-023-2423-1","article-title":"Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors","volume":"67","author":"He","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.cellsig.2024.111439_bb0020","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2024.111439_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1098-2388(199611\/12)12:6<386::AID-SSU3>3.0.CO;2-6","article-title":"Surgical therapy of primary cutaneous melanoma","volume":"12","author":"Geraghty","year":"1996","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5694\/mja17.00278","article-title":"Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma","volume":"208","author":"Sladden","year":"2018","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.cellsig.2024.111439_bb0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(06)70758-6","article-title":"Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma","volume":"7","author":"Stevens","year":"2006","journal-title":"Lancet Oncol."},{"issue":"170","key":"10.1016\/j.cellsig.2024.111439_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejca.2022.04.018","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022","volume":"1990","author":"Garbe","year":"2022","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"10.1016\/j.cellsig.2024.111439_bb0045","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2024.111439_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0060","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2024.111439_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.cellsig.2024.111439_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/bbrc.1997.6371","article-title":"cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix\/PAS protein (BMAL1) and identification of alternatively spliced variants with alternative translation initiation site usage","volume":"233","author":"Ikeda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2024.111439_bb0075","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature00906","article-title":"A transcription factor response element for gene expression during circadian night","volume":"418","author":"Ueda","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2024.111439_bb0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1126\/science.aaw7365","article-title":"Circadian rhythms in the absence of the clock gene Bmal1","volume":"367","author":"Ray","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2024.111439_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/420373a","article-title":"Circadian rhythms: the cancer connection","volume":"420","author":"Rosbash","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2024.111439_bb0090","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.jcmgh.2021.08.001","article-title":"The circadian clock gene, Bmal1, regulates intestinal stem cell signaling and represses tumor initiation","volume":"12","author":"Stokes","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2214829120","article-title":"Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle","volume":"120","author":"Qu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111439_bb0100","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/jcm9040934","article-title":"MRI study of paraspinal muscles in patients with amyotrophic lateral sclerosis (ALS)","volume":"9","author":"Diamanti","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cellsig.2024.111439_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.canlet.2015.12.002","article-title":"The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway","volume":"371","author":"Jiang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2024.111439_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216826","article-title":"LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer","volume":"590","author":"Gao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2024.111439_bb0115","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/jnci\/93.20.1563","article-title":"Rotating night shifts and risk of breast cancer in women participating in the nurses\u2019 health study","volume":"93","author":"Schernhammer","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2024.111439_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/jnci\/95.11.825","article-title":"Night-shift work and risk of colorectal cancer in the nurses\u2019 health study","volume":"95","author":"Schernhammer","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellsig.2024.111439_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s42003-022-03425-6","article-title":"Melanopsin (Opn4) is an oncogene in cutaneous melanoma","volume":"5","author":"de Assis","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbrc.2016.02.087","article-title":"Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma","volume":"472","author":"Li","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2024.111439_bb0135","article-title":"Disruption of the clock component Bmal1 in mice promotes cancer metastasis through the PAI-1-TGF-\u03b2-myoCAF-dependent mechanism","volume":"10","author":"Wu","year":"2023","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.cellsig.2024.111439_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.cellsig.2024.111439_bb0145","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cellsig.2024.111439_bb0150","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2024.111439_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fonc.2018.00185","article-title":"Expression of the circadian clock gene BMAL1 positively correlates with antitumor immunity and patient survival in metastatic melanoma","volume":"8","author":"de Assis","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112187","article-title":"Silencing BMAL1 promotes M1\/M2 polarization through the LDHA\/lactate axis to promote GBM sensitivity to bevacizumab","volume":"134","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0165","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1073\/pnas.1915932117","article-title":"The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumonia","volume":"117","author":"Kitchen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111439_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A neutrophil Timer coordinates immune defense and vascular protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2024.111439_bb0175","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3389\/fimmu.2019.02451","article-title":"Pan-Cancer analysis reveals disrupted circadian clock associates with T cell exhaustion","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0180","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.cell.2024.04.015","article-title":"Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2024.111439_bb0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u2018N1\u2019 versus \u2018N2\u2019 TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2024.111439_bb0190","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0002-9440(10)63580-8","article-title":"Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression","volume":"163","author":"Tazawa","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0195","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1073\/pnas.0712185105","article-title":"Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression","volume":"105","author":"Shojaei","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111439_bb0200","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00394-021-02677-y","article-title":"L-Theanine inhibits melanoma cell growth and migration via regulating expression of the clock gene BMAL1","volume":"61","author":"Zhang","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.cellsig.2024.111439_bb0205","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.27598","article-title":"The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma","volume":"131","author":"Elshazley","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellsig.2024.111439_bb0210","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.18632\/aging.103124","article-title":"BMAL1 knockdown triggers different colon carcinoma cell fates by altering the delicate equilibrium between AKT\/mTOR and P53\/P21 pathways","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.cellsig.2024.111439_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112111","article-title":"BMAL1 alleviates myocardial damage in sepsis by activating SIRT1 signaling and promoting mitochondrial autophagy","volume":"133","author":"Tang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2024.111439_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220551120","article-title":"Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes","volume":"120","author":"McKee","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellsig.2024.111439_bb0225","first-page":"C231","article-title":"Circadian clock regulates granulosa cell autophagy through NR1D1-mediated inhibition of ATG5","volume":"322","author":"Zhang","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cellsig.2024.111439_bb0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3892\/mmr.2022.12819","article-title":"Role of ROS-mediated autophagy in melanoma (review)","volume":"26","author":"Zhang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.cellsig.2024.111439_bb0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10103-018-2489-6","article-title":"ROS-induced autophagy reduces B16F10 melanoma cell proliferative activity","volume":"33","author":"Santos","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.cellsig.2024.111439_bb0240","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/ijms25052929","article-title":"Neutrophils at the crossroads: unraveling the multifaceted role in the tumor microenvironment","volume":"25","author":"Awasthi","year":"2024","journal-title":"Int. J. Mol. Sci."}],"updated-by":[{"DOI":"10.1016\/j.cellsig.2025.112205","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000}},{"DOI":"10.1016\/j.cellsig.2025.112205","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824004121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656824004121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:28:09Z","timestamp":1768462089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656824004121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":48,"alternative-id":["S0898656824004121"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111439","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bmal1 upregulates ATG5 expression to promote autophagy in skin cutaneous melanoma","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2024.111439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111439"}}